Patents by Inventor Francisco Romero Millan

Francisco Romero Millan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of thaxtomin for selective control of rice and aquatic based weeds
    Patent number: 9339034
    Abstract: The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fields with no phytotoxicity to rice as well as on aquatic based weeds.
    Type: Grant
    Filed: April 15, 2010
    Date of Patent: May 17, 2016
    Assignee: MARRONE BIO INNOVATIONS, INC.
    Inventors: Daniel C Leep, Lisa Doricchi, Maria Julia Perez Baz, Francisco Romero Millan, Rosa Isabel Fernandez Chimeno
  • Use of collismycin and derivatives thereof as oxidative stress inhibitors
    Patent number: 8067441
    Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.
    Type: Grant
    Filed: July 28, 2006
    Date of Patent: November 29, 2011
    Assignees: Neuropharma, S.A., Instituto Biomar, S.A.
    Inventors: Ana Martinez Gil, Paola Usan Egea, Miguel Medina Padilla, Esther Garcia Palomero, Julia Perez Baz, Rosa Isabel Fernandez Chimeno, Antonio Medarde Fernandez, Librada Maria Canedo Hernandez, Francisco Romero Millan, Ana Castro Morera, Mercedes Alonso Cascon, Jorge Sanchez Quesada
  • Use of Thaxtomin for Selective Control of Rice and Aquatic Based Weeds
    Publication number: 20100267560
    Abstract: The use of a bacterial secondary metabolite, thaxtomin is described as an effective herbicide on broadleaved, sedge and grass weeds, e.g., in rice fields with no phytotoxicity to rice as well as on aquatic based weeds.
    Type: Application
    Filed: April 15, 2010
    Publication date: October 21, 2010
    Applicant: MARRONE BIO INNOVATIONS, INC.
    Inventors: Daniel C. Leep, Lisa Doricchi, Rosa Isabel Fernandez Chimeno, Maria Julia Perez Baz, Francisco Romero Millan
  • USE OF COLLISMYCIN AND DERIVATIVES THEREOF AS OXIDATIVE STRESS INHIBITORS
    Publication number: 20100048635
    Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment and/or prevention of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.
    Type: Application
    Filed: July 28, 2006
    Publication date: February 25, 2010
    Applicants: Neuropharma, S.A., Instituto Biomar, S.A.
    Inventors: Ana Martinez Gil, Paola Egea, Miguel Medina Padilla, Esther Palomero, Julia Perez Baz, Rosa Fernandez Chimeno, Antonio Medarde Fernandez, Librada Canedo Hernandez, Francisco Romero Millan, Ana Castro Morera, Mercedes Alonso Cascon, Jorge Sanchez Quesada
  • Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
    Publication number: 20080275088
    Abstract: The present invention relates to the use of Collismycin and derivatives thereof as inhibitors of oxidative stress in cells and their use for the preparation of medicaments for the treatment and/or prevention of oxidative stress-induced diseases or conditions, especially neurodegenerative diseases, such as Alzheimer's Disease and Parkinson's Disease.
    Type: Application
    Filed: July 28, 2006
    Publication date: November 6, 2008
    Applicants: NEUROPHARMA, S.A., INSTITUTO BIOMAR, S.A.
    Inventors: Ana Martinez Gil, Paola Usan Egea, Miguel Medina Padilla, Esther Garcia Palomero, Julia Perez Baz, Rosa Isabel Fernandez Chimeno, Antonio Medarde Fernandez, Librada Maria Canedo Hernandez, Francisco Romero Millan, Ana Castro Morera, Mercedes Alonso Cascon, Jorge Sanchez Quesada
  • Use of citreamicins
    Publication number: 20030236291
    Abstract: Citreamicins possess useful antitumor activity. Typically they are of formula, wherein R1 is selected from the group consisting of COCH2CH(CH3)2, COCH3 or H when R2 is CH3, or wherein R1 is COCH2CH(CH3)2, and R2 is H.
    Type: Application
    Filed: July 25, 2003
    Publication date: December 25, 2003
    Inventors: Dolores Garcia Gravalos, Jose Luis Fernandez Puentes, Librada Maria Canedo Fernandez, Julia Perez-Baz, Francisco Romero-Millan, Fernando Espliego-Vazquez
  • Immunosuppressive sesbanimide compositions and methods of treatment using same
    Publication number: 20010039041
    Abstract: The active component of the pharmaceutical composition of the present invention is a compound which has been isolated from the controlled aerobic fermentation of a marine microorganism, Agrobacterium sp. PH-103.
    Type: Application
    Filed: January 8, 2001
    Publication date: November 8, 2001
    Applicant: Pharma Mar, S.a.
    Inventors: Glynn T. Faircloth, Francisco Romero Millan, Librada Maria Canedo Fernandez, Cristina Accbal Sarabia
  • Method of treating tumors with thiodepsipeptide isolated from a marine actinomycete
    Patent number: 6214793
    Abstract: The present invention is directed to a novel depsipeptide has been isolated from a new marine strain L-13-ACM2-092 belonging to the family Micromonosporaceae. Its production by aerobic fermentation under controlled conditions of the strain, and the isolation and purification of PM-93135 are described herein. The compound and the fermentation broth demonstrate significant activity against several cancer cell lines. The compound also shows activity against several gram positive bacteria.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: April 10, 2001
    Assignee: Pharma Mar, s.a.
    Inventors: Julia Perez Baz, Francisco Romero Millan, Teresa Garcia De Quesada, Dolores Garcia Gravalos
  • Thiodepsipeptide isolated from a marine actinomycete
    Patent number: 5849540
    Abstract: The present invention is directed to a novel depsipeptide has been isolated from a new marine strain L-13-ACM2-092 belonging to the family Micromonosporaceae. Its production by aerobic fermentation under controlled conditions of the strain, and the isolation and purification of PM-93135 are described herein. The compound and the fermentation broth demonstrate significant activity against several cancer cell lines. The compound also shows activity against several gram positive bacteria.
    Type: Grant
    Filed: September 24, 1997
    Date of Patent: December 15, 1998
    Assignee: Pharma Mar, S.A.
    Inventors: Julia Perez Baz, Francisco Romero Millan, Teresa Garcia De Quesada, Dolores Garcia Gravalos
  • Thiodepsipeptide isolated from a marine actinomycete
    Patent number: 5681813
    Abstract: The present invention is directed to a novel depsipeptide has been isolated from a new marine strain L-13-ACM2-092 belonging to the family Micromonosporaceae. Its production by aerobic fermentation under controlled conditions of the strain, and the isolation and purification of PM-93135 are described herein. The compound and the fermentation broth demonstrate significant activity against several cancer cell lines. The compound also shows activity against several gram positive bacteria.
    Type: Grant
    Filed: April 6, 1994
    Date of Patent: October 28, 1997
    Assignee: Pharma Mar, s.a.
    Inventors: Julia Perez Baz, Francisco Romero Millan, Teresa Garcia De Quesada, Dolores Garcia Gravalos